» Authors » Robert Mannel

Robert Mannel

Explore the profile of Robert Mannel including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 765
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mayadev J, Zamarin D, Deng W, Lankes H, Pesci G, Kim H, et al.
Nat Commun . 2025 Jan; 16(1):553. PMID: 39788967
Combined immune checkpoint blockade (ICB) and chemoradiation (CRT) is approved in patients with locally advanced cervical cancer (LACC) but optimal sequencing of CRT and ICB is unknown. NRG-GY017 (NCT03738228) was...
2.
ODwyer P, Wolmark N, Hawkins D, Schnall M, Dancey J, Blanke C, et al.
J Clin Oncol . 2024 Sep; 42(33):3905-3910. PMID: 39288338
No abstract available.
3.
Abdoli N, Zhang K, Gilley P, Chen X, Sadri Y, Thai T, et al.
Bioengineering (Basel) . 2023 Nov; 10(11). PMID: 38002458
2D and 3D tumor features are widely used in a variety of medical image analysis tasks. However, for chemotherapy response prediction, the effectiveness between different kinds of 2D and 3D...
4.
Eskander R, Sill M, Beffa L, Moore R, Hope J, Musa F, et al.
N Engl J Med . 2023 Mar; 388(23):2159-2170. PMID: 36972022
Background: Standard first-line chemotherapy for endometrial cancer is paclitaxel plus carboplatin. The benefit of adding pembrolizumab to chemotherapy remains unclear. Methods: In this double-blind, placebo-controlled, randomized, phase 3 trial, we...
5.
Oonk M, Slomovitz B, Baldwin P, van Doorn H, van der Velden J, de Hullu J, et al.
J Clin Oncol . 2021 Aug; 39(32):3623-3632. PMID: 34432481
Purpose: The Groningen International Study on Sentinel nodes in Vulvar cancer (GROINSS-V)-II investigated whether inguinofemoral radiotherapy is a safe alternative to inguinofemoral lymphadenectomy (IFL) in vulvar cancer patients with a...
6.
Hossen M, Elechalawar C, Sjoelund V, Moore K, Mannel R, Bhattacharya R, et al.
Cancer Nanotechnol . 2021 Jan; 12(1):1. PMID: 33456622
Background: Ovarian cancer is one of the deadliest gynecological malignancies. While the overall survival of ovarian cancer patients has slightly improved in recent years in the developed world, it remains...
7.
Tewari K, Sill M, Coleman R, Aghajanian C, Mannel R, DiSilvestro P, et al.
Gynecol Oncol . 2020 Jul; 159(1):79-87. PMID: 32723679
Objective: To explore the relationship between tumor size and response to combined anti-vascular targeted therapy using the anti-angiogenesis inhibitor, bevacizumab, and the tubulin-binding vascular disrupting agent, fosbretabulin. Methods: An exploratory,...
8.
Chakraborty P, Mustafi S, Xiong X, Dwivedi S, Nesin V, Saha S, et al.
Nat Commun . 2017 May; 8:14634. PMID: 28530221
Cancer cells actively promote aerobic glycolysis to sustain their metabolic requirements through mechanisms not always clear. Here, we demonstrate that the gatekeeper of mitochondrial Ca uptake, Mitochondrial Calcium Uptake 1...
9.
Atri M, Zhang Z, Marques H, Gorelick J, Harisinghani M, Sohaib A, et al.
Eur J Radiol Open . 2015 Mar; 2:11-18. PMID: 25774381
Rationale And Objectives: To assess if ferumoxtran-10 (f-10) improves accuracy of MRI to detect lymph node (LN) metastasis in advanced cervical cancer. Materials And Methods: F-10 MRI component of an...
10.
Farley J, Brady W, Vathipadiekal V, Lankes H, Coleman R, Morgan M, et al.
Lancet Oncol . 2012 Dec; 14(2):134-40. PMID: 23261356
Background: Low-grade serous carcinoma of the ovary is chemoresistant but mutations in the MAPK pathway could be targeted to control tumour growth. We therefore assessed the safety and activity of...